DMTC’s Medical Countermeasures Program is growing with Round 2 projects announced by the Minister for Defence Industry, the Hon Christopher Pyne MP.
Medical countermeasures (MCMs) are vaccines, therapeutics and/or diagnostics against chemical, biological and radiological threat, emerging infectious disease and pandemics.
The new projects follow on from the first round of DMTC’s MCM Program that has been underway for around 15 months.
With its priorities set by Defence, seed funding for the DMTC MCM program has been provided by CSIRO and the Defence Science & Technology Group through its Next Generation Technologies Fund (NGTF). The aim of the MCM program is to accelerate the advanced development and deployment of countermeasures, with technical expertise from industry and research partners.
Under DMTC’s proven co-investment model, funding provided by Government customer agencies is leveraged by contributions of cash and resources from industry and research partners.
The Minister’s press release is available here and more details will be available on our website as soon as contract negotiations and project agreements are complete.
Posted by DMTC Tagged: collaboration, Countermeasures, CSIRO, defence technology, DST